Association of Tumor Necrosis Factor Inhibitor Treatment With Reduced Indices of Subclinical Atherosclerosis in Patients With Psoriatic Disease.
Lihi EderAditya A JoshiAmit K DeyRichard CookEvan L SiegelDafna D GladmanNehal N MehtaPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2018)
Our findings indicate that TNFi treatment is associated with reduced progression of carotid plaques in men and improvement in vascular inflammation in both men and women with psoriatic disease.